Kyverna Therapeutics, Inc : H.c. Wainwright Initiates Coverage With Neutral Rating and Target Price $8
Kyverna Therapeutics, Inc:H.C. Wainwright發起覆蓋,評級爲中性,目標價爲8美元。
Kyverna Therapeutics, Inc : H.c. Wainwright Initiates Coverage With Neutral Rating and Target Price $8
Kyverna Therapeutics, Inc:H.C. Wainwright發起覆蓋,評級爲中性,目標價爲8美元。
譯文內容由第三人軟體翻譯。